Premium
Trixeo Aerosphere: a triple‐combination inhaler for COPD
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1957
Subject(s) - medicine , formoterol , inhaler , copd , budesonide , metered dose inhaler , adverse effect , budesonide/formoterol , dry powder inhaler , formoterol fumarate , asthma , anesthesia , pharmacology
Trixeo Aerosphere (formoterol/glycopyrronium/budesonide) is a metered‐dose triple‐combination inhaler for the treatment of moderate to severe COPD. This article summarises its indications, clinical trial efficacy and adverse effects.